Literature DB >> 36257961

Clinical variant interpretation and biologically relevant reference transcripts.

Fernando Pozo1, José Manuel Rodriguez2, Jesús Vázquez2,3, Michael L Tress4.   

Abstract

Clinical variant interpretation is highly dependent on the choice of reference transcript. Although the longest transcript has traditionally been chosen as the reference, APPRIS principal and MANE Select transcripts, biologically supported reference sequences, are now available. In this study, we show that MANE Select and APPRIS principal transcripts are the best reference transcripts for clinical variation. APPRIS principal and MANE Select transcripts capture almost all ClinVar pathogenic variants, and they are particularly powerful over the 94% of coding genes in which they agree. We find that a vanishingly small number of ClinVar pathogenic variants affect alternative protein products. Alternative isoforms that are likely to be clinically relevant can be predicted using TRIFID scores, the highest scoring alternative transcripts are almost 700 times more likely to house pathogenic variants. We believe that APPRIS, MANE and TRIFID are essential tools for clinical variant interpretation.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36257961      PMCID: PMC9579139          DOI: 10.1038/s41525-022-00329-6

Source DB:  PubMed          Journal:  NPJ Genom Med        ISSN: 2056-7944            Impact factor:   6.083


  47 in total

1.  Novel NOBOX loss-of-function mutations account for 6.2% of cases in a large primary ovarian insufficiency cohort.

Authors:  Justine Bouilly; Anne Bachelot; Isabelle Broutin; Philippe Touraine; Nadine Binart
Journal:  Hum Mutat       Date:  2011-09-09       Impact factor: 4.878

Review 2.  Protein Data Bank (PDB): The Single Global Macromolecular Structure Archive.

Authors:  Stephen K Burley; Helen M Berman; Gerard J Kleywegt; John L Markley; Haruki Nakamura; Sameer Velankar
Journal:  Methods Mol Biol       Date:  2017

Review 3.  Alternative splicing as a source of phenotypic diversity.

Authors:  Charlotte J Wright; Christopher W J Smith; Chris D Jiggins
Journal:  Nat Rev Genet       Date:  2022-07-12       Impact factor: 59.581

4.  Delta-thalassemia caused by disruption of the site for an erythroid-specific transcription factor, GATA-1, in the delta-globin gene promoter.

Authors:  M Matsuda; N Sakamoto; Y Fukumaki
Journal:  Blood       Date:  1992-09-01       Impact factor: 22.113

Review 5.  The Function of Tafazzin, a Mitochondrial Phospholipid-Lysophospholipid Acyltransferase.

Authors:  Michael Schlame; Yang Xu
Journal:  J Mol Biol       Date:  2020-03-29       Impact factor: 5.469

6.  ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007.

Authors:  C Sue Richards; Sherri Bale; Daniel B Bellissimo; Soma Das; Wayne W Grody; Madhuri R Hegde; Elaine Lyon; Brian E Ward
Journal:  Genet Med       Date:  2008-04       Impact factor: 8.822

7.  APPRIS: annotation of principal and alternative splice isoforms.

Authors:  Jose Manuel Rodriguez; Paolo Maietta; Iakes Ezkurdia; Alessandro Pietrelli; Jan-Jaap Wesselink; Gonzalo Lopez; Alfonso Valencia; Michael L Tress
Journal:  Nucleic Acids Res       Date:  2012-11-17       Impact factor: 16.971

8.  The Ensembl Variant Effect Predictor.

Authors:  William McLaren; Laurent Gil; Sarah E Hunt; Harpreet Singh Riat; Graham R S Ritchie; Anja Thormann; Paul Flicek; Fiona Cunningham
Journal:  Genome Biol       Date:  2016-06-06       Impact factor: 13.583

9.  Rare Variants in BNC2 Are Implicated in Autosomal-Dominant Congenital Lower Urinary-Tract Obstruction.

Authors:  Caroline M Kolvenbach; Gabriel C Dworschak; Sandra Frese; Anna S Japp; Peggy Schuster; Nina Wenzlitschke; Öznur Yilmaz; Filipa M Lopes; Alexey Pryalukhin; Luca Schierbaum; Loes F M van der Zanden; Franziska Kause; Ronen Schneider; Katarzyna Taranta-Janusz; Maria Szczepańska; Krzysztof Pawlaczyk; William G Newman; Glenda M Beaman; Helen M Stuart; Raimondo M Cervellione; Wouter F J Feitz; Iris A L M van Rooij; Michiel F Schreuder; Martijn Steffens; Stefanie Weber; Waltraut M Merz; Markus Feldkötter; Bernd Hoppe; Holger Thiele; Janine Altmüller; Christoph Berg; Glen Kristiansen; Michael Ludwig; Heiko Reutter; Adrian S Woolf; Friedhelm Hildebrandt; Phillip Grote; Marcin Zaniew; Benjamin Odermatt; Alina C Hilger
Journal:  Am J Hum Genet       Date:  2019-05-02       Impact factor: 11.025

10.  A novel X-linked gene, G4.5. is responsible for Barth syndrome.

Authors:  S Bione; P D'Adamo; E Maestrini; A K Gedeon; P A Bolhuis; D Toniolo
Journal:  Nat Genet       Date:  1996-04       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.